Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M603085200 on June 7, 2006

J. Biol. Chem., Vol. 281, Issue 32, 23119-23128, August 11, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
281/32/23119    most recent
M603085200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, A. K.
Right arrow Articles by Sahu, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, A. K.
Right arrow Articles by Sahu, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Functional Characterization of the Complement Control Protein Homolog of Herpesvirus Saimiri

ARG-118 IS CRITICAL FOR FACTOR I COFACTOR ACTIVITIES*Formula

Akhilesh K. Singh1, Jayati Mullick, John Bernet, and Arvind Sahu2

From the National Centre for Cell Science, Pune University Campus, Ganeshkhind, Pune 411007, India

Herpesvirus saimiri (HVS) is a lymphotropic virus that causes T-cell lymphomas in New World primates. It encodes a structural homolog of complement control proteins named complement control protein homolog (CCPH). Previously, CCPH has been shown to inhibit C3d deposition on target cells exposed to complement. Here we have studied the mechanism by which it inactivates complement. We have expressed the soluble form of CCPH in Escherichia coli, purified to homogeneity and compared its activity to vaccinia virus complement control protein (VCP) and human complement regulators factor H and soluble complement receptor 1. The expressed soluble form of CCPH bound to C3b (KD = 19.2 µM) as well as to C4b (KD = 0.8 µM) and accelerated the decay of the classical/lectin as well as alternative pathway C3-convertases. In addition, it also served as factor I cofactor and supported factor I-mediated inactivation of both C3b and C4b. Time course analysis indicated that although its rate of inactivation of C4b is comparable with VCP, it is 14-fold more potent than VCP in inactivating C3b. Site-directed mutagenesis revealed that Arg-118, which corresponds to Lys-120 of variola virus complement regulator SPICE (a residue critical for its enhanced C3b cofactor activity), contributes significantly in enhancing this activity. Thus, our data indicate that HVS encodes a potent complement inhibitor that allows HVS to evade the host complement attack.


Received for publication, March 31, 2006 , and in revised form, June 7, 2006.

* This work was supported by the Wellcome Trust Senior Research Fellowship in Biomedical Science in India (to A. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1 and 2.

1 Supported by a research fellowship from the Council of Scientific and Industrial Research, India. This work was performed in partial fulfillment of a Ph.D. thesis, which will be submitted to the University of Pune, Pune, India.

2 To whom correspondence should be addressed. Tel.: 91-20-2569-0922; Fax: 91-20-2569-2259; E-mail: arvindsahu{at}nccs.res.in.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Okroj, L. Mark, A. Stokowska, S. W. Wong, N. Rose, D. J. Blackbourn, B. O. Villoutreix, O. B. Spiller, and A. M. Blom
Characterization of the Complement Inhibitory Function of Rhesus Rhadinovirus Complement Control Protein (RCP)
J. Biol. Chem., January 2, 2009; 284(1): 505 - 514.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. N. Yadav, K. Pyaram, J. Mullick, and A. Sahu
Identification of Hot Spots in the Variola Virus Complement Inhibitor (SPICE) for Human Complement Regulation
J. Virol., April 1, 2008; 82(7): 3283 - 3294.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Kuttner-Kondo, D. E. Hourcade, V. E. Anderson, N. Muqim, L. Mitchell, D. C. Soares, P. N. Barlow, and M. E. Medof
Structure-based Mapping of DAF Active Site Residues That Accelerate the Decay of C3 Convertases
J. Biol. Chem., June 22, 2007; 282(25): 18552 - 18562.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement